Sugi Predict

Sugi Predict / Compounds / SCHEMBL136625

SCHEMBL136625

SCHEMBL136625

COc1ccc(CO[C@H]2[C@@H](O)C(OC)OC2(COS(C)(=O)=O)COS(C)(=O)=O)cc1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ APLNR P35414 2/20 0.36
▸ NPC1 O15118 2/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ POLB P06746 2/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ GJB2 P29033 1/20 0.32
▸ GJA1 P17302 1/20 0.32
▸ IDO1 P14902 2/20 0.32
▸ AGXT P21549 2/20 0.32
▸ SLC5A2 P31639 3/20 0.32
▸ SLC5A1 P13866 2/20 0.32
▸ P2RX4 Q99571 1/20 0.32
▸ TLR9 Q9NR96 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14511262 1.00 APLNR (0.36) APLNRNPC1RAB9APOLBSMN1; SMN2
SCHEMBL135297 0.96 APLNR (0.34) APLNRNPC1RAB9APOLBSMN1; SMN2
SCHEMBL136626 0.88 APLNR (0.37) APLNRNPC1RAB9APOLBSMN1; SMN2
SCHEMBL1097290 0.85 BCHE (0.36) IDO1ALDH1A1
SCHEMBL135298 0.84 APLNR (0.34) APLNRIDO1AGXTP2RX4TLR9
SCHEMBL14511261 0.80 GJB2 (0.36) NPC1RAB9APOLBSMN1; SMN2GJB2
SCHEMBL17417930 0.78 GRM2 (0.32) —
SCHEMBL16061468 0.78 GRM2 (0.32) —
SCHEMBL133350 0.77 APLNR (0.36) APLNRIDO1AGXTTLR9ALDH1A1
SCHEMBL14511263 0.77 APLNR (0.36) APLNRIDO1AGXTTLR9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9464106-B2 Oligonucleotides useful for detecting and analyzing nucleic acids of interest EXIQON A/S (DK) 2016-10-11 — — US disclosed
US-20120157333-A1 OLIGONUCLEOTIDES USEFUL FOR DETECTING AND ANALYZING NUCLEIC ACIDS OF INTEREST EXIQON A/S (DK) 2012-06-21 — — US disclosed
EP-1446412-B1 NOVEL LNA COMPOSITIONS AND USES THEREOF EXIQON AS (DK) 2012-03-07 — — EP disclosed
US-20070117144-A1 Oligonucleotides useful for detecting and analyzing nucleic acids of interest EXIQON A/S (DK) 2007-05-24 — — US disclosed
US-20040219565-A1 Oligonucleotides useful for detecting and analyzing nucleic acids of interest EXIQON A/S (DK) 2004-11-04 — — US disclosed
EP-1446412-A2 NOVEL LNA COMPOSITIONS AND USES THEREOF Exiqon A/S (DK) 2004-08-18 — — EP disclosed
US-20030224377-A1 Novel LNA compositions and uses thereof QIAGEN GMBH (DE) 2003-12-04 — — US disclosed
WO-2003020739-A2 NOVEL LNA COMPOSITIONS AND USES THEREOF EXIQON A/S (DK) 2003-03-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040219565-A1 Oligonucleotides useful for detecting and analyzing nucleic acids of interest UPF1, DCLRE1B, SNRPA1 APLNR 704/4885NPC1 2968/4885RAB9A 3952/4885
US-20030224377-A1 Novel LNA compositions and uses thereof RNGTT, NCL, NSUN2 APLNR 1353/4885NPC1 2081/4885RAB9A 2919/4885
US-20120157333-A1 OLIGONUCLEOTIDES USEFUL FOR DETECTING AND ANALYZING NUCLEIC ACIDS OF INTEREST UPF1, DCLRE1B, SNRPA1 APLNR 704/4885NPC1 2968/4885RAB9A 3952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.